{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:07:11Z","timestamp":1791328031418,"version":"4.3.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00401-013-1114-9","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T12:22:12Z","timestamp":1366287732000},"page":"795-813","source":"Crossref","is-referenced-by-count":455,"title":["Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease"],"prefix":"10.1007","volume":"125","author":[{"given":"Jens","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Ryazanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Leonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Prix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pan-Montojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Mitteregger-Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Geissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Leidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hirschberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas A.","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian J.","family":"Krauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Zinth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Pilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zweckstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen H.","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Urlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Samwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"B\u00f6tzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Groschup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"1114_CR1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","volume":"9","author":"E Angot","year":"2010","unstructured":"Angot E, Steiner JA, Hansen C, Li JY, Brundin P (2010) Are synucleinopathies prion-like disorders? Lancet Neurol 9:1128\u20131138","journal-title":"Lancet Neurol"},{"key":"1114_CR2","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1128\/JVI.79.12.7785-7791.2005","volume":"79","author":"U Bertsch","year":"2005","unstructured":"Bertsch U, Winklhofer KF, Hirschberger T, Bieschke J, Weber P, Hartl FU, Tavan P, Tatzelt J, Kretzschmar HA, Giese A (2005) Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J Virol 79:7785\u20137791","journal-title":"J Virol"},{"key":"1114_CR3","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1073\/pnas.97.10.5468","volume":"97","author":"J Bieschke","year":"2000","unstructured":"Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA 97:5468\u20135473","journal-title":"Proc Natl Acad Sci USA"},{"key":"1114_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.719","volume":"8","author":"J Bieschke","year":"2011","unstructured":"Bieschke J, Herbst M, Wiglenda T, Friedrich RP, Boeddrich A, Schiele F, Kleckers D, Lopez del Amo JM, Gruning BA, Wang Q, Schmidt MR, Lurz R, Anwyl R, Schnoegl S, Fandrich M, Frank RF, Reif B, Gunther S, Walsh DM, Wanker EE (2011) Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils. Nat Chem Biol 8:93\u2013101","journal-title":"Nat Chem Biol"},{"key":"1114_CR5","doi-asserted-by":"crossref","first-page":"12207","DOI":"10.1073\/pnas.0404650101","volume":"101","author":"J Bieschke","year":"2004","unstructured":"Bieschke J, Weber P, Sarafoff N, Beekes M, Giese A, Kretzschmar H (2004) Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci USA 101:12207\u201312211","journal-title":"Proc Natl Acad Sci USA"},{"key":"1114_CR6","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/emboj\/20.13.3351","volume":"20","author":"CR Birkett","year":"2001","unstructured":"Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, Bruce ME, Bostock CJ (2001) Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 20:3351\u20133358","journal-title":"EMBO J"},{"key":"1114_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13506120500106958","volume":"12","author":"G Bitan","year":"2005","unstructured":"Bitan G, Fradinger EA, Spring SM, Teplow DB (2005) Neurotoxic protein oligomers\u2014what you see is not always what you get. Amyloid 12:88\u201395","journal-title":"Amyloid"},{"key":"1114_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.40.6.887","volume":"40","author":"P Brown","year":"1990","unstructured":"Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887\u2013890","journal-title":"Neurology"},{"key":"1114_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290","journal-title":"Neurobiol Dis"},{"key":"1114_CR10","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/emboj.2008.181","volume":"27","author":"J Castilla","year":"2008","unstructured":"Castilla J, Morales R, Saa P, Barria M, Gambetti P, Soto C (2008) Cell-free propagation of prion strains. EMBO J 27:2557\u20132566","journal-title":"EMBO J"},{"key":"1114_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267\u2013298","journal-title":"Annu Rev Neurosci"},{"key":"1114_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1359-6446(03)02827-7","volume":"8","author":"DE Clark","year":"2003","unstructured":"Clark DE (2003) In silico prediction of blood\u2013brain barrier permeation. Drug Discov Today 8:927\u2013933","journal-title":"Drug Discov Today"},{"key":"1114_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519\u2013550","journal-title":"Annu Rev Neurosci"},{"key":"1114_CR14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","volume":"8","author":"J Collinge","year":"2009","unstructured":"Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S, Rossor M, Rudge P, Siddique D, Spyer M, Thomas D, Walker S, Webb T, Wroe S, Darbyshire J (2009) Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 8:334\u2013344","journal-title":"Lancet Neurol"},{"key":"1114_CR15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00705-009-0471-0","volume":"154","author":"L Colombo","year":"2009","unstructured":"Colombo L, Piovesan P, Ghirardi O, Salmona M, Forloni G (2009) ST1859 reduces prion infectivity and increase survival in experimental scrapie. Arch Virol 154:1539\u20131544","journal-title":"Arch Virol"},{"key":"1114_CR16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.sbi.2009.12.009","volume":"20","author":"S Connelly","year":"2010","unstructured":"Connelly S, Choi S, Johnson SM, Kelly JW, Wilson IA (2010) Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol 20:54\u201362","journal-title":"Curr Opin Struct Biol"},{"key":"1114_CR17","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1128\/JVI.71.12.9685-9689.1997","volume":"71","author":"R Demaimay","year":"1997","unstructured":"Demaimay R, Adjou KT, Beringue V, Demart S, Lasmezas CI, Deslys JP, Seman M, Dormont D (1997) Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J Virol 71:9685\u20139689","journal-title":"J Virol"},{"key":"1114_CR18","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010\u201313015","journal-title":"Proc Natl Acad Sci USA"},{"key":"1114_CR19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2005.07.021","volume":"47","author":"MS Forman","year":"2005","unstructured":"Forman MS, Lee VM, Trojanowski JQ (2005) Nosology of Parkinson\u2019s disease: looking for the way out of a quagmire. Neuron 47:479\u2013482","journal-title":"Neuron"},{"key":"1114_CR20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","volume":"10","author":"MS Forman","year":"2004","unstructured":"Forman MS, Trojanowski JQ, Lee VM (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055\u20131063","journal-title":"Nat Med"},{"key":"1114_CR21","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"1114_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2011-110182","volume":"24","author":"BS Gadad","year":"2011","unstructured":"Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. J Alzheimer\u2019s Dis 24(Suppl 2):223\u2013232","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1114_CR23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/jm101250y","volume":"54","author":"A Gallardo-Godoy","year":"2011","unstructured":"Gallardo-Godoy A, Gever J, Fife KL, Silber BM, Prusiner SB, Renslo AR (2011) 2-Aminothiazoles as therapeutic leads for prion diseases. J Med Chem 54:1010\u20131021","journal-title":"J Med Chem"},{"key":"1114_CR24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjp.0706072","volume":"144","author":"V Gayrard","year":"2005","unstructured":"Gayrard V, Picard-Hagen N, Viguie C, Laroute V, Andreoletti O, Toutain PL (2005) A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie. Br J Pharmacol 144:386\u2013393","journal-title":"Br J Pharmacol"},{"key":"1114_CR25","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cmdc.201100119","volume":"6","author":"M Geissen","year":"2011","unstructured":"Geissen M, Leidel F, Eiden M, Hirschberger T, Fast C, Bertsch U, Tavan P, Giese A, Kretzschmar H, Schatzl HM, Groschup MH (2011) From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease. Chem Med Chem 6:1928\u20131937","journal-title":"Chem Med Chem"},{"key":"1114_CR26","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/JVI.02145-09","volume":"84","author":"S Ghaemmaghami","year":"2010","unstructured":"Ghaemmaghami S, May BC, Renslo AR, Prusiner SB (2010) Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol 84:3408\u20133412","journal-title":"J Virol"},{"key":"1114_CR27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bbrc.2005.06.025","volume":"333","author":"A Giese","year":"2005","unstructured":"Giese A, Bader B, Bieschke J, Schaffar G, Odoy S, Kahle PJ, Haass C, Kretzschmar H (2005) Single particle detection and characterization of synuclein co-aggregation. Biochem Biophys Res Commun 333:1202\u20131210","journal-title":"Biochem Biophys Res Commun"},{"key":"1114_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1995.tb00597.x","volume":"5","author":"A Giese","year":"1995","unstructured":"Giese A, Groschup MH, Hess B, Kretzschmar HA (1995) Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 5:213\u2013221","journal-title":"Brain Pathol"},{"key":"1114_CR29","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1212\/01.wnl.0000192103.24796.42","volume":"66","author":"CG Glabe","year":"2006","unstructured":"Glabe CG, Kayed R (2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66:S74\u2013S78","journal-title":"Neurology"},{"key":"1114_CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-1759(97)00121-X","volume":"207","author":"MH Groschup","year":"1997","unstructured":"Groschup MH, Harmeyer S, Pfaff E (1997) Antigenic features of prion proteins of sheep and of other mammalian species. J Immunol Methods 207:89\u2013101","journal-title":"J Immunol Methods"},{"key":"1114_CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","volume":"66","author":"JD Harper","year":"1997","unstructured":"Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer\u2019s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66:385\u2013407","journal-title":"Annu Rev Biochem"},{"key":"1114_CR32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bpj.2012.01.059","volume":"102","author":"T H\u00f6gen","year":"2012","unstructured":"H\u00f6gen T, Levin J, Schmidt F, Caruana M, Vassallo N, Kretzschmar H, Botzel K, Kamp F, Giese A (2012) Two different binding modes of alpha-synuclein to lipid vesicles depending on its aggregation state. Biophys J 102:1646\u20131655","journal-title":"Biophys J"},{"key":"1114_CR33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-4159.2011.07254.x","volume":"117","author":"S H\u00fcls","year":"2011","unstructured":"H\u00fcls S, H\u00f6gen T, Vassallo N, Danzer KM, Hengerer B, Giese A, Herms J (2011) AMPA-receptor-mediated excitatory synaptic transmission is enhanced by iron-induced alpha-synuclein oligomers. J Neurochem 117:868\u2013878","journal-title":"J Neurochem"},{"key":"1114_CR34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2119\/2007-00100.Irvine","volume":"14","author":"GB Irvine","year":"2008","unstructured":"Irvine GB, El Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: the molecular basis for Alzheimer\u2019s and Parkinson\u2019s diseases. Mol Med 14:451\u2013464","journal-title":"Mol Med"},{"key":"1114_CR35","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MB, Kugler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, Kumar A, Riedel D, Fichtner L, Voigt A, Braus GH, Giller K, Becker S, Herzig A, Baldus M, Jackle H, Eimer S, Schulz JB, Griesinger C, Zweckstetter M (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J 28:3256\u20133268","journal-title":"EMBO J"},{"key":"1114_CR36","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1128\/JVI.01563-07","volume":"81","author":"Y Kawasaki","year":"2007","unstructured":"Kawasaki Y, Kawagoe K, Chen CJ, Teruya K, Sakasegawa Y, Doh-ura K (2007) Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner. J Virol 81:12889\u201312898","journal-title":"J Virol"},{"key":"1114_CR37","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","volume":"98","author":"C Korth","year":"2001","unstructured":"Korth C, May BC, Cohen FE, Prusiner SB (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98:9836\u20139841","journal-title":"Proc Natl Acad Sci USA"},{"key":"1114_CR38","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1074\/jbc.M709634200","volume":"283","author":"M Kostka","year":"2008","unstructured":"Kostka M, H\u00f6gen T, Danzer KM, Levin J, Habeck M, Wirth A, Wagner R, Glabe CG, Finger S, Heinzelmann U, Garidel P, Duan W, Ross CA, Kretzschmar H, Giese A (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283:10992\u201311003","journal-title":"J Biol Chem"},{"key":"1114_CR39","doi-asserted-by":"crossref","first-page":"21057","DOI":"10.1073\/pnas.0902603106","volume":"106","author":"GR Lamberto","year":"2009","unstructured":"Lamberto GR, Binolfi A, Orcellet ML, Bertoncini CW, Zweckstetter M, Griesinger C, Fernandez CO (2009) Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation. Proc Natl Acad Sci USA 106:21057\u201321062","journal-title":"Proc Natl Acad Sci USA"},{"key":"1114_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","volume":"418","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418:291","journal-title":"Nature"},{"key":"1114_CR41","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1128\/AAC.00151-11","volume":"55","author":"F Leidel","year":"2011","unstructured":"Leidel F, Eiden M, Geissen M, Kretzschmar HA, Giese A, Hirschberger T, Tavan P, Schatzl HM, Groschup MH (2011) Diphenylpyrazole-derived compounds increase survival time of mice after prion infection. Antimicrob Agents Chemother 55:4774\u20134781","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"1114_CR43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209:975\u2013986","journal-title":"J Exp Med"},{"key":"1114_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","volume":"53","author":"GR Mallucci","year":"2007","unstructured":"Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J (2007) Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53:325\u2013335","journal-title":"Neuron"},{"key":"1114_CR45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"1114_CR46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/194979a0","volume":"194","author":"P Mueller","year":"1962","unstructured":"Mueller P, Rudin DO, Tien HT, Wescott WC (1962) Reconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature 194:979\u2013980","journal-title":"Nature"},{"key":"1114_CR47","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","volume":"110","author":"M Neumann","year":"2002","unstructured":"Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W, Muller V, Odoy S, Fujiwara H, Hasegawa M, Iwatsubo T, Trojanowski JQ, Kretzschmar HA, Haass C (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110:1429\u20131439","journal-title":"J Clin Invest"},{"key":"1114_CR48","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762","journal-title":"PLoS One"},{"key":"1114_CR49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898. doi: 10.1038\/srep00898","journal-title":"Sci Rep"},{"key":"1114_CR50","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1172\/JCI29236","volume":"116","author":"A Pfeifer","year":"2006","unstructured":"Pfeifer A, Eigenbrod S, Al Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H (2006) Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 116:3204\u20133210","journal-title":"J Clin Invest"},{"key":"1114_CR51","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363\u201313383","journal-title":"Proc Natl Acad Sci USA"},{"key":"1114_CR52","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-4159.1980.tb03693.x","volume":"35","author":"SB Prusiner","year":"1980","unstructured":"Prusiner SB, Garfin DE, Cochran SP, McKinley MP, Groth DF, Hadlow WJ, Race RE, Eklund CM (1980) Experimental scrapie in the mouse: electrophoretic and sedimentation properties of the partially purified agent. J Neurochem 35:574\u2013582","journal-title":"J Neurochem"},{"key":"1114_CR53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810\u2013813","journal-title":"Nature"},{"key":"1114_CR54","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","volume":"4","author":"J Safar","year":"1998","unstructured":"Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4:1157\u20131165","journal-title":"Nat Med"},{"issue":"8","key":"1114_CR55","doi-asserted-by":"crossref","first-page":"e42545","DOI":"10.1371\/journal.pone.0042545","volume":"7","author":"F Schmidt","year":"2012","unstructured":"Schmidt F, Levin J, Kamp F, Kretzschmar H, Giese A, Botzel K (2012) Single-channel electrophysiology reveals a distinct and uniform pore complex formed by alpha-synuclein oligomers in lipid membranes. PLoS One 7(8):e42545","journal-title":"PLoS One"},{"key":"1114_CR56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","volume":"17","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe DJ (2011) Resolving controversies on the path to Alzheimer\u2019s therapeutics. Nat Med 17:1060\u20131065","journal-title":"Nat Med"},{"key":"1114_CR57","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312","journal-title":"Nat Genet"},{"key":"1114_CR58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archneurol.2007.56","volume":"65","author":"C Soto","year":"2008","unstructured":"Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65:184\u2013189","journal-title":"Arch Neurol"},{"key":"1114_CR59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mds.25017","volume":"27","author":"JR Streffer","year":"2012","unstructured":"Streffer JR, Grachev ID, Fitzer-Attas C, Gomez-Mancilla B, Boroojerdi B, Bronzova J, Ostrowitzki S, Victor SJ, Fontoura P, Alexander R (2012) Prerequisites to launch neuroprotective trials in Parkinson\u2019s disease: an industry perspective. Mov Disord 27:651\u2013655","journal-title":"Mov Disord"},{"key":"1114_CR60","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.ejmech.2011.06.013","volume":"46","author":"MJ Thompson","year":"2011","unstructured":"Thompson MJ, Louth JC, Ferrara S, Jackson MP, Sorrell FJ, Cochrane EJ, Gever J, Baxendale S, Silber BM, Roehl HH, Chen B (2011) Discovery of 6-substituted indole-3-glyoxylamides as lead antiprion agents with enhanced cell line activity, improved microsomal stability and low toxicity. Eur J Med Chem 46:4125\u20134132","journal-title":"Eur J Med Chem"},{"key":"1114_CR61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson\u2019s disease. Lancet Neurol 5:75\u201386","journal-title":"Lancet Neurol"},{"key":"1114_CR62","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","volume":"129","author":"CR Trevitt","year":"2006","unstructured":"Trevitt CR, Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129:2241\u20132265","journal-title":"Brain"},{"key":"1114_CR63","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1021\/bi025958g","volume":"41","author":"S Tzaban","year":"2002","unstructured":"Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A (2002) Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41:12868\u201312875","journal-title":"Biochemistry"},{"key":"1114_CR64","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623","journal-title":"J Med Chem"},{"key":"1114_CR65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","volume":"358","author":"JD Wadsworth","year":"2001","unstructured":"Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171\u2013180","journal-title":"Lancet"},{"key":"1114_CR66","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1126\/science.1151839","volume":"319","author":"C Wasmer","year":"2008","unstructured":"Wasmer C, Lange A, van Melckebeke H, Siemer AB, Riek R, Meier BH (2008) Amyloid fibrils of the HET-s(218\u2013289) prion form a beta solenoid with a triangular hydrophobic core. Science 319:1523\u20131526","journal-title":"Science"},{"key":"1114_CR67","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1073\/pnas.0605608103","volume":"103","author":"P Weber","year":"2006","unstructured":"Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, Kretzschmar HA (2006) Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc Natl Acad Sci USA 103:15818\u201315823","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-013-1114-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1114-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1114-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T12:04:48Z","timestamp":1595678688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-013-1114-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1114"],"URL":"https:\/\/doi.org\/10.1007\/s00401-013-1114-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718021753.793479027","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718021753.793529100","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]}}}